Intimation of the Cut-off date of the AGM of the Company "SHELTER PHARMA LIMITED" to be held on Tuesday 29th September, 2026.

Date: 01st September, 2026 BSE Limited, Floor 25, P J Towers, Dalal Street, Mumbai – 400001 Script Code: 543963 Sub.: Outcome of Board Meeting of The Company Held on the Tuesday, 01ST September, 2026 at 01.45 PM. Ref.: Disclosure under Regulation 30 and all other applicable Regulations, if any, of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, (the Listing Regulations) as amended from time to time. Dear Sir/Madam, The Board of Directors of the Company at their meeting held on Tuesday, 01ST September, 2026 at 01:45 PM. At the corporate office of the company at 5th Floor, 501 Sakar 4, Opp. MJ Library Ashram Road Paldi, Ellisbridge, Ahmedabad-380006, Gujarat, India, have discussed and approved following major businesses: 1. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors approved the regularization of Ms. Vinita Shivraj Gadhvi (DIN: 09102407) as a Non-Executive Independent Director of the Company for a term of Five consecutive years with effect from 31st July, 2026 till 30th July, 2031, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM). During her tenure, she shall not be liable to retire by rotation. The Additional details of Ms. Vinita Shivraj Gadhvi (DIN: 09102407) as required under Schedule Ill - Para A (7) of Part A of SEBI Listing Regulations read with Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January, 2026 are enclosed as Annexure- 2. Re-appointment of Mrs. Parvezbanu Mohamed Rafiq Idariya (DIN: 01470286) as a Director, who retires by rotation in terms of Section 152(6) of the Companies Act, 2013 and, being eligible, offers herself for re- appointment. 3. To ratify and approve material transactions conducted with related parties during Financial Year 2025–26. 4. To Approve Material Related Party Transaction(s) to be entered into by the Company during the Financial Year 2026-27, pursuant to Section 188 of the Companies Act, 2013 read with the rules made thereunder and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 subject to approval of Shareholders of the Company. 5. The 19th Annual General Meeting of the Company will be held on Tuesday, 29th September, 2026 at 10:00 A.M. at registered office of the company at Shelter Nagar, Nr. S. T. Bus Stand, Himmatnagar GJ 383001 IN Gujarat for the Financial Year ended on 31st March, 2026; 6. Approved Notice for calling of the 19th Annual General Meeting ("AGM") of the Company and approved Directors' Report (Board Report) along with its annexures, Management Discussion and Analysis Report (MDAR), and Annual Report for the Financial Year 2025-2026; Further, the Company has fixed Friday, 28th August, 2026, as the cut- off date to determine the list of eligible members for dispatching the Notice of the 19th Annual General Meeting along with Annual Report for the Financial Year 2025-2026. 7. Fixed Tuesday, 22nd September, 2026, as the Cut-off to determine the eligibility of members to attend and vote (including remote e-voting) at the 19th Annual General Meeting (AGM) of the Company, scheduled to be held on Tuesday, September 29, 2026, at 10:00 A.M. The remote e-voting facility will commence from Saturday, 26th September 2026, and will end on Monday, 28th September 2026. Members can vote from 9:00 a.m. to 5:00 p.m. during the above- mentioned period. 8. The board has appointed M/s. Murtuza Mandorwala & Associates, Practicing Company Secretary as a Scrutinizer to scrutinize the remote e- voting process and the votes casted through Ballot Paper during the 19th Annual General Meeting of the Company. The Board Meeting outcome will be made available at our website at https://shelter.co.in. The Meeting of Board of Directors Concluded at 02.15 P.M. Kindly take the above on record. Thanking You. FOR, SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR MANAGING DIRECTOR DIN: 01456841 Place: Ahmedabad Annexure A Details of Ms. Vinita Shivraj Gadhvi (DIN: 09102407) (as required under Schedule Ill - Para A (7) of Part A of SEBI Listing Regulations read with Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026: Name Ms. Vinita Shivraj Gadhvi (DIN: 09102407) Reason for Change viz Appointment/Regularization of Ms. appointment, Resignation, Vinita Shivraj Gadhvi (DIN: 09102407) removal, death or otherwise as a Non-Executive Independent Director of the Company Date of Appointment Ms. Vinita Shivraj Gadhvi has been appointed for a term of 5 (five) consecutive years with effect from 31st July, 2026 till 30th July, 2031, not liable to retire by rotation, subject to approval of shareholders Brief Profile Dr. Vinita Gadhavi is an accomplished entrepreneur, business strategist, and healthcare professional with over 12 years of experience spanning pharmaceuticals, healthcare innovation, consumer brands, quality systems, research, and strategic growth. Academically, she holds a Ph.D. focused on the Indian Healthcare Startup Ecosystem, an MBA in Total Quality Management, a B.Pharm, and was awarded a Gold Medal for her M.Pharm in Quality Assurance from Gujarat Technological University. Over her professional career, Dr. Gadhavi has held several key strategic and leadership positions. Her major focus areas include quality assurance, regulatory compliance, strategic business development, R&D commercialization, and startup ecosystem assessment. Dr. Gadhavi has been recognized with innovation grants from SSIP, GUSEC, and i-Hub Gujarat, won the State-Level HerSTART Entrepreneurship Competition, and has been featured in the Government publication "Women in Startups" as well as India TV’s "Leader Betiya" program for her contributions to healthcare innovation and research. Disclosure of relationship Ms. Vinita Shivraj Gadhvi is neither between directors related inter se nor with any other existing Director(s) of the Company Information as required under Ms. Vinita Shivraj Gadhvi is not Circular No. debarred from holding of office of a LIST/COMP/14/2018-19 Director by virtue of any SEBI order or issued by the BSE any other such authority.